DalsnaFinance › Analyst accuracy › UBS › RGEN target

UBS’s $225 target on RGEN

RGEN Repligen
$195 → $225 (+16%) by Sep 2027
Buy · reiterates · said Sep 29, 2026 · 12-month default horizon
Open: judged on the close on Sep 29, 2027

The article this target came from

Repligen stock price target reaffirmed at $225 by UBS on growth outlook

Investing.com · Sep 29, 2026
Repligen stock price target reaffirmed at $225 by UBS on growth outlook

A fact about what UBS published, as reported by Investing.com, not a recommendation from Dalsna Finance; UBS is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.